Skip Navigation

European Heart Journal 1995 16(Supplement A):11-15; doi:10.1093/eurheartj/16.suppl_A.11
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smith, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, E. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Fibrinogen, Fibrin and the Arterial Wall

E. B. Smith

Department of Clinical Biochemistry, University of Aberdeen Foresterhill, Aberdeen, U.K.

Correspondenc: E. B. Smith, Department of Clinical Biochemistry, University of Aberdeen, Foresterhill, Aberdeen, U.K.

Virtually all plasma proteins, including fibrinogen, low density lipoprotein and lipoprotein (a), are present in normal arterial intima and in atherosclerotic lesions, and their concentrations are related to plasma concentrations. Fibrin is also a significant component of many lesions, particularly early proliferative (gelatinous) lesions, where it may be present both in the deep layers and on the intimal surface. The fibrin strands provide a scaffold along which smooth muscle cells migrate and proliferate, bind thrombin, and are a source of fibrin degradation products (FDPs), which are mitogenic. Very recent studies suggest that free a-thrombin may be present in lesions despite an apparent excess of antithrombin III, so this may promote fibrin formation within the lesion. Furthermore, fibrinolysis and FDP generation may be mediated by catheptic enzymes in addition to plasmin.

Key Words: Fibrinogen • fibrin • smooth muscle cell • vascular intima • thrombosis • atherogenesis • lipoprotein


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
E. Falk, S. M. Schwartz, Z. S. Galis, and M. E. Rosenfeld
Putative Murine Models of Plaque Rupture
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 969 - 972.
[Full Text] [PDF]

Home page
 JAMAHome page
Fibrinogen Studies Collaboration*
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-analysis
JAMA, October 12, 2005; 294(14): 1799 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
O. Iqbal, H. Messmore, D. Hoppensteadt, J. Fareed, and W. Wehrmacher
State-of-the-Art Review : Thrombolytic Drugs in Acute Myocardial Infarction
Clinical and Applied Thrombosis/Hemostasis, January 1, 2000; 6(1): 1 - 13.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.